On the contrary, in the other studies, therapy with HES 130/0.4 neither resulted in higher serum creatinine (sCr) concentrations, nor in increased urinary biomarkers of AKI, including neutrophil gelatinase-associated lipocalin [10,11,12,13,14]. The gene discussed is LCN2; the disease is acute kidney injury.